Page 5 - Dcph News Today

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) traded down 3.8% during trading on Thursday . The company traded as low as $14.75 and last traded at $14.77. 17,708 shares were traded during trading, a decline of 98% from the average session volume of 814,655 shares. The stock had previously closed at $15.36. Wall Street Analyst […]

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) rose 6.6% on Monday . The stock traded as high as $15.53 and last traded at $15.50. Approximately 37,453 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 825,850 shares. The stock had previously closed at $14.54. Wall Street […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating)’s share price fell 8.1% during mid-day trading on Tuesday . The stock traded as low as $14.56 and last traded at $14.67. 357,192 shares traded hands during trading, a decline of 58% from the average session volume of 854,974 shares. The stock had previously closed at $15.96. Analyst […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) has been assigned an average rating of “Moderate Buy” from the ten brokerages that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the […]

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) have been given a consensus rating of “Moderate Buy” by the ten ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and six have assigned a buy recommendation to […]

Teacher Retirement System of Texas purchased a new stake in shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) during the 3rd quarter, HoldingsChannel reports. The firm purchased 12,935 shares of the company’s stock, valued at approximately $239,000. Other hedge funds and other institutional investors have also added to or reduced their stakes in the […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities researchers at SVB Leerink reduced their FY2026 earnings per share estimates for Deciphera Pharmaceuticals in a note issued to investors on Wednesday, January 4th. SVB Leerink analyst A. Berens now expects that the company will earn $3.38 per share for the year, down from their previous […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) insider Jama Pitman sold 1,298 shares of the company’s stock in a transaction dated Thursday, June 16th. The shares were sold at an average price of $10.75, for a total transaction of $13,953.50. Following the completion of the transaction, the insider now directly owns 36,661 shares in the […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) EVP Matthew L. Sherman sold 1,768 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Thursday, June 16th. The shares were sold at an average price of $10.75, for a total transaction of $19,006.00. Following the sale, the executive vice president now owns 76,884 shares of […]

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) – Equities researchers at Jefferies Financial Group lifted their Q2 2022 earnings estimates for Deciphera Pharmaceuticals in a research report issued on Wednesday, May 4th. Jefferies Financial Group analyst E. Yang now expects that the company will post earnings of ($0.70) per share for the quarter, up from […]